{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:39:16Z","timestamp":1793759956708,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.antiviral.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T16:39:13Z","timestamp":1323707953000},"page":"305-308","source":"Crossref","is-referenced-by-count":25,"title":["Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone"],"prefix":"10.1016","volume":"93","author":[{"given":"Sharon E.","family":"Altmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori E.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Paragas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.12.001_b0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/infdis\/jiq103","article-title":"Evaluation of therapeutic interventions for vaccinia virus keratitis","volume":"203","author":"Altmann","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.12.001_b0010","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1128\/JVI.00621-10","article-title":"Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models","volume":"84","author":"Americo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"Buller","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.12.001_b0020","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection","volume":"80","author":"Chaudhri","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0025","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0402949101","article-title":"Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox","volume":"101","author":"Chaudhri","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.12.001_b0030","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3748\/wjg.15.5669","article-title":"Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV","volume":"15","author":"Dang","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.12.001_b0040","doi-asserted-by":"crossref","first-page":"13392","DOI":"10.1128\/JVI.00770-07","article-title":"Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly","volume":"81","author":"Deng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1177\/135965350701200802","article-title":"Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures","volume":"12","author":"Duraffour","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2011.12.001_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2009.08.026","article-title":"Zoonotic poxviruses","volume":"140","author":"Essbauer","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.137.2.727","article-title":"Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function","volume":"137","author":"Fidler","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0060","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4049\/jimmunol.136.8.2747","article-title":"Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice","volume":"136","author":"Fidler","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0065","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.63.12_suppl_6.S15","article-title":"Mechanism of action of mitoxantrone","volume":"63","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.antiviral.2011.12.001_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1099\/vir.0.005108-0","article-title":"A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus","volume":"90","author":"Hutson","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0075","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1128\/JVI.02723-07","article-title":"Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly","volume":"82","author":"Lin","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug\u2013drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.12.001_b0085","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.12.001_b0090","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.12.001_b0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/jm00255a011","article-title":"Bis-basic-substituted polycyclic aromatic compounds. New class of antiviral agents. 5. Bis-basic ethers of anthraquinone and bisalkamine esters of anthraquinone dicarboxylic acids","volume":"17","author":"Sill","year":"1974","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2011.12.001_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"Smee","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.12.001_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox","author":"Smith","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3201\/eid1009.040310","article-title":"Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkey pox virus","volume":"10","author":"Tesh","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.12.001_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0404.2009.01295.x","article-title":"Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines","volume":"122","author":"Vogelgesang","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.antiviral.2011.12.001_b0120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee","volume":"46","author":"Vora","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.12.001_b0125","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against Vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.12.001_b0130","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T18:40:30Z","timestamp":1686508830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211005201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0166354211005201"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.12.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}